Home/ Stocks/ CTSO

Cytosorbents Corp.

CTSO XNAS

$0.61 -0.00 (-0.08%) ▼ 15-min delayed

Open

$0.63

High

$0.63

Low

$0.60

Volume

40.8K

Market Cap

$38.25M

About Cytosorbents Corp.

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

Sector: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Employees: 129 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$37.06M	$-8,198,000	$-0.13
FY 2025	$37.06M	$-8,198,000	$-0.13
Q3 2025	$9.48M	$-3,170,000	$-0.05
Q2 2025	$9.62M	$1.95M	$0.03

Related Market News

No specific coverage for CTSO yet. Check out our latest market news or earnings calendar.

Get CTSO Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Cytosorbents Corp..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.